Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Non-controlling Interest	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021			153,950,895
Beginning balance at Dec. 31, 2021	$ 670,881,000	$ (75,264,000)	$ 16,000	$ 1,691,206,000	$ (87,946,000)	$ (1,009,293,000)	$ 12,682,000	$ (11,220,000)	$ 172,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			27,443,580
Issuance of common stock, net of offering costs	203,796,000		$ 2,000	203,794,000
Exercise of common stock warrants (in shares)			540,541
Exercise of warrants	10,249,000			10,249,000
Exercise of stock options (in shares)			349,847
Exercise of stock options	443,000			443,000
Delivery of common stock underlying restricted stock units (in shares)			392,326
Stock-based compensation	19,449,000			19,449,000
Foreign currency translation adjustment	(2,215,000)								(2,215,000)
Net loss attributable to non-controlling interest	(93,000)							(93,000)
Net loss attributable to common shareholders	(140,724,000)					(140,724,000)
Ending balance at Mar. 31, 2022	$ 686,522,000		$ 18,000	1,837,195,000		(1,137,335,000)		(11,313,000)	(2,043,000)
Ending balance (in shares) at Mar. 31, 2022			182,677,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update	Accounting Standards Update 2020-06 [Member]
Beginning balance (in shares) at Dec. 31, 2021			153,950,895
Beginning balance at Dec. 31, 2021	$ 670,881,000	$ (75,264,000)	$ 16,000	1,691,206,000	$ (87,946,000)	(1,009,293,000)	$ 12,682,000	(11,220,000)	172,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss attributable to non-controlling interest	(243,000)
Net loss attributable to common shareholders	(256,848,000)
Ending balance at Jun. 30, 2022	600,134,000		$ 19,000	1,867,924,000		(1,253,459,000)		(11,463,000)	(2,887,000)
Ending balance (in shares) at Jun. 30, 2022			185,293,067
Beginning balance (in shares) at Mar. 31, 2022			182,677,189
Beginning balance at Mar. 31, 2022	686,522,000		$ 18,000	1,837,195,000		(1,137,335,000)		(11,313,000)	(2,043,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			2,400,000
Issuance of common stock, net of offering costs	16,392,000		$ 1,000	16,391,000
Exercise of stock options (in shares)			80,275
Exercise of stock options	129,000			129,000
Delivery of common stock underlying restricted stock units (in shares)			135,603
Stock-based compensation	14,209,000			14,209,000
Foreign currency translation adjustment	(844,000)								(844,000)
Net loss attributable to non-controlling interest	(150,000)							(150,000)
Net loss attributable to common shareholders	(116,124,000)					(116,124,000)
Ending balance at Jun. 30, 2022	$ 600,134,000		$ 19,000	1,867,924,000		(1,253,459,000)		(11,463,000)	(2,887,000)
Ending balance (in shares) at Jun. 30, 2022			185,293,067
Beginning balance (in shares) at Dec. 31, 2022	209,684,548		209,684,548
Beginning balance at Dec. 31, 2022	$ 401,682,000		$ 21,000	1,972,006,000		(1,558,088,000)		(11,662,000)	(595,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			71,444,729
Issuance of common stock, net of offering costs	106,057,000		$ 7,000	106,050,000
Exercise of stock options (in shares)			28,663
Exercise of stock options	46,000			46,000
Cancellation of escrow shares in connection with Edisn acquisition (in shares)			(12,595)
Cancellation of escrow shares in connection with Edisn acquisition	(344,000)			(344,000)
Delivery of common stock underlying restricted stock units (in shares)			454,462
Stock-based compensation	11,738,000			11,738,000
Molotov non-controlling interest	(499,000)			(864,000)				374,000	(9,000)
Foreign currency translation adjustment	2,756,000								2,756,000
Net loss attributable to non-controlling interest	(11,000)							(11,000)
Net loss attributable to common shareholders	(83,613,000)					(83,613,000)
Ending balance at Mar. 31, 2023	$ 437,812,000		$ 28,000	2,088,632,000		(1,641,701,000)		(11,299,000)	2,152,000
Ending balance (in shares) at Mar. 31, 2023			281,599,807
Beginning balance (in shares) at Dec. 31, 2022	209,684,548		209,684,548
Beginning balance at Dec. 31, 2022	$ 401,682,000		$ 21,000	1,972,006,000		(1,558,088,000)		(11,662,000)	(595,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	190,488
Net loss attributable to non-controlling interest	$ (21,000)
Net loss attributable to common shareholders	(133,553,000)
Ending balance at Jun. 30, 2023	$ 410,114,000		$ 29,000	2,110,746,000		(1,691,641,000)		(11,309,000)	2,289,000
Ending balance (in shares) at Jun. 30, 2023	292,559,125		292,559,125
Beginning balance (in shares) at Mar. 31, 2023			281,599,807
Beginning balance at Mar. 31, 2023	$ 437,812,000		$ 28,000	2,088,632,000		(1,641,701,000)		(11,299,000)	2,152,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering costs (in shares)			10,250,000
Issuance of common stock, net of offering costs	10,855,000		$ 1,000	10,854,000
Exercise of stock options (in shares)			161,825
Exercise of stock options	49,000			49,000
Delivery of common stock underlying restricted stock units (in shares)			547,493
Delivery of common stock underlying restricted stock units	0			0
Stock-based compensation	11,211,000			11,211,000
Foreign currency translation adjustment	137,000								137,000
Net loss attributable to non-controlling interest	(10,000)							(10,000)
Net loss attributable to common shareholders	(49,940,000)					(49,940,000)
Ending balance at Jun. 30, 2023	$ 410,114,000		$ 29,000	$ 2,110,746,000		$ (1,691,641,000)		$ (11,309,000)	$ 2,289,000
Ending balance (in shares) at Jun. 30, 2023	292,559,125		292,559,125